APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza Drugs and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Influenza Drugs and Vaccines Market Analysis and Forecast 2026-2032

26 December 2025210 pages

Choose your research edition.

Industry ResearchInfluenza Drugs and Vaccines Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Drugs and Vaccines Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Influenza Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Drugs and Vaccines Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Drugs and Vaccines Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Influenza Drugs and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Influenza Drugs and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Influenza Drugs and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Influenza Drugs and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Influenza Drugs and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Influenza Drugs and Vaccines include CSL, Alvogen, AstraZeneca, BioCryst Pharmaceuticals, Bristol Myers Squibb, Celgene, Emergent Biosolutions, GlaxoSmithKline and Hulan Bio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Influenza Drugs and Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Influenza Drugs and Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Influenza Drugs and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Influenza Drugs and Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Influenza Drugs and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Influenza Drugs and Vaccines sales, projected growth trends, production technology, application and end-user industry.

Influenza Drugs and Vaccines Segment by Company

CSL

Alvogen

AstraZeneca

BioCryst Pharmaceuticals

Bristol Myers Squibb

Celgene

Emergent Biosolutions

GlaxoSmithKline

Hulan Bio

Protein Sciences Corporation

Seqirus

Serum Institute of India

Viatris

Beike Bio

Bayer

Pfizer

Jiangsu GDK

Sinovac

Eli Lilly

Roche

Novartis

Sanofi

Changchun Institute of Biological

Influenza Drugs and Vaccines Segment by Type

Influenza Drugs

Influenza Vaccines

Influenza Drugs and Vaccines Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Influenza Drugs and Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Drugs and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Drugs and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Drugs and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Influenza Drugs and Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza Drugs and Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Influenza Drugs and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Influenza Drugs Major Manufacturers Table 3. Influenza Vaccines Major Manufacturers Table 4. Global Influenza Drugs and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacy Major Manufacturers Table 6. Online Pharmacy Major Manufacturers Table 7. Hospital Pharmacy Major Manufacturers Table 8. Influenza Drugs and Vaccines Industry Trends Table 9. Influenza Drugs and Vaccines Industry Drivers Table 10. Influenza Drugs and Vaccines Industry Opportunities and Challenges Table 11. Influenza Drugs and Vaccines Industry Restraints Table 12. Global Influenza Drugs and Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Influenza Drugs and Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Influenza Drugs and Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2021-2026) Table 16. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2027-2032) Table 17. Global Influenza Drugs and Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 18. Global Influenza Drugs and Vaccines Sales by Region (2021-2026) & (Tons) Table 19. Global Influenza Drugs and Vaccines Sales by Region (2027-2032) & (Tons) Table 20. Global Influenza Drugs and Vaccines Sales Market Share by Region (2021-2026) Table 21. Global Influenza Drugs and Vaccines Sales Market Share by Region (2027-2032) Table 22. Global Influenza Drugs and Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Influenza Drugs and Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2021-2026) Table 26. Global Influenza Drugs and Vaccines Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 27. Global Influenza Drugs and Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Influenza Drugs and Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Influenza Drugs and Vaccines Manufacturers, Product Type & Application Table 30. Global Influenza Drugs and Vaccines Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Influenza Drugs and Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Influenza Drugs and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Influenza Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Influenza Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2021-2026) Table 37. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2027-2032) Table 38. Global Influenza Drugs and Vaccines Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 39. Global Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 40. Global Influenza Drugs and Vaccines Sales by Type (2027-2032) & (Tons) Table 41. Global Influenza Drugs and Vaccines Sales Market Share by Type (2021-2026) Table 42. Global Influenza Drugs and Vaccines Sales Market Share by Type (2027-2032) Table 43. Global Influenza Drugs and Vaccines Price by Type (2021-2026) & (US$/Kg) Table 44. Global Influenza Drugs and Vaccines Price by Type (2027-2032) & (US$/Kg) Table 45. Global Influenza Drugs and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Influenza Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Influenza Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2021-2026) Table 49. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2027-2032) Table 50. Global Influenza Drugs and Vaccines Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 51. Global Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 52. Global Influenza Drugs and Vaccines Sales by Application (2027-2032) & (Tons) Table 53. Global Influenza Drugs and Vaccines Sales Market Share by Application (2021-2026) Table 54. Global Influenza Drugs and Vaccines Sales Market Share by Application (2027-2032) Table 55. Global Influenza Drugs and Vaccines Price by Application (2021-2026) & (US$/Kg) Table 56. Global Influenza Drugs and Vaccines Price by Application (2027-2032) & (US$/Kg) Table 57. CSL Company Information Table 58. CSL Business Overview Table 59. CSL Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 60. CSL Influenza Drugs and Vaccines Product Portfolio Table 61. CSL Recent Development Table 62. Alvogen Company Information Table 63. Alvogen Business Overview Table 64. Alvogen Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 65. Alvogen Influenza Drugs and Vaccines Product Portfolio Table 66. Alvogen Recent Development Table 67. AstraZeneca Company Information Table 68. AstraZeneca Business Overview Table 69. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. AstraZeneca Influenza Drugs and Vaccines Product Portfolio Table 71. AstraZeneca Recent Development Table 72. BioCryst Pharmaceuticals Company Information Table 73. BioCryst Pharmaceuticals Business Overview Table 74. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio Table 76. BioCryst Pharmaceuticals Recent Development Table 77. Bristol Myers Squibb Company Information Table 78. Bristol Myers Squibb Business Overview Table 79. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio Table 81. Bristol Myers Squibb Recent Development Table 82. Celgene Company Information Table 83. Celgene Business Overview Table 84. Celgene Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Celgene Influenza Drugs and Vaccines Product Portfolio Table 86. Celgene Recent Development Table 87. Emergent Biosolutions Company Information Table 88. Emergent Biosolutions Business Overview Table 89. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio Table 91. Emergent Biosolutions Recent Development Table 92. GlaxoSmithKline Company Information Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio Table 96. GlaxoSmithKline Recent Development Table 97. Hulan Bio Company Information Table 98. Hulan Bio Business Overview Table 99. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Hulan Bio Influenza Drugs and Vaccines Product Portfolio Table 101. Hulan Bio Recent Development Table 102. Protein Sciences Corporation Company Information Table 103. Protein Sciences Corporation Business Overview Table 104. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio Table 106. Protein Sciences Corporation Recent Development Table 107. Seqirus Company Information Table 108. Seqirus Business Overview Table 109. Seqirus Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Seqirus Influenza Drugs and Vaccines Product Portfolio Table 111. Seqirus Recent Development Table 112. Serum Institute of India Company Information Table 113. Serum Institute of India Business Overview Table 114. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. Serum Institute of India Influenza Drugs and Vaccines Product Portfolio Table 116. Serum Institute of India Recent Development Table 117. Viatris Company Information Table 118. Viatris Business Overview Table 119. Viatris Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 120. Viatris Influenza Drugs and Vaccines Product Portfolio Table 121. Viatris Recent Development Table 122. Beike Bio Company Information Table 123. Beike Bio Business Overview Table 124. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 125. Beike Bio Influenza Drugs and Vaccines Product Portfolio Table 126. Beike Bio Recent Development Table 127. Bayer Company Information Table 128. Bayer Business Overview Table 129. Bayer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 130. Bayer Influenza Drugs and Vaccines Product Portfolio Table 131. Bayer Recent Development Table 132. Pfizer Company Information Table 133. Pfizer Business Overview Table 134. Pfizer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 135. Pfizer Influenza Drugs and Vaccines Product Portfolio Table 136. Pfizer Recent Development Table 137. Jiangsu GDK Company Information Table 138. Jiangsu GDK Business Overview Table 139. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 140. Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio Table 141. Jiangsu GDK Recent Development Table 142. Sinovac Company Information Table 143. Sinovac Business Overview Table 144. Sinovac Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 145. Sinovac Influenza Drugs and Vaccines Product Portfolio Table 146. Sinovac Recent Development Table 147. Eli Lilly Company Information Table 148. Eli Lilly Business Overview Table 149. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 150. Eli Lilly Influenza Drugs and Vaccines Product Portfolio Table 151. Eli Lilly Recent Development Table 152. Roche Company Information Table 153. Roche Business Overview Table 154. Roche Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 155. Roche Influenza Drugs and Vaccines Product Portfolio Table 156. Roche Recent Development Table 157. Novartis Company Information Table 158. Novartis Business Overview Table 159. Novartis Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 160. Novartis Influenza Drugs and Vaccines Product Portfolio Table 161. Novartis Recent Development Table 162. Sanofi Company Information Table 163. Sanofi Business Overview Table 164. Sanofi Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 165. Sanofi Influenza Drugs and Vaccines Product Portfolio Table 166. Sanofi Recent Development Table 167. Changchun Institute of Biological Company Information Table 168. Changchun Institute of Biological Business Overview Table 169. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 170. Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio Table 171. Changchun Institute of Biological Recent Development Table 172. North America Influenza Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 173. North America Influenza Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 174. North America Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 175. North America Influenza Drugs and Vaccines Sales by Type (2027-2032) & (Tons) Table 176. North America Influenza Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Kg) Table 177. North America Influenza Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Kg) Table 178. North America Influenza Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 179. North America Influenza Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 180. North America Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 181. North America Influenza Drugs and Vaccines Sales by Application (2027-2032) & (Tons) Table 182. North America Influenza Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Kg) Table 183. North America Influenza Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Kg) Table 184. North America Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. North America Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. North America Influenza Drugs and Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. North America Influenza Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 188. North America Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 189. North America Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 190. North America Influenza Drugs and Vaccines Sales Price by Country (2021-2026) & (US$/Kg) Table 191. North America Influenza Drugs and Vaccines Sales Price by Country (2027-2032) & (US$/Kg) Table 192. United States Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 193. Canada Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 194. Mexico Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 195. Europe Influenza Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 196. Europe Influenza Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 197. Europe Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 198. Europe Influenza Drugs and Vaccines Sales by Type (2027-2032) & (Tons) Table 199. Europe Influenza Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Kg) Table 200. Europe Influenza Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Kg) Table 201. Europe Influenza Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 202. Europe Influenza Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 203. Europe Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 204. Europe Influenza Drugs and Vaccines Sales by Application (2027-2032) & (Tons) Table 205. Europe Influenza Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Kg) Table 206. Europe Influenza Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Kg) Table 207. Europe Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Europe Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Europe Influenza Drugs and Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Europe Influenza Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 211. Europe Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 212. Europe Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 213. Europe Influenza Drugs and Vaccines Sales Price by Country (2021-2026) & (US$/Kg) Table 214. Europe Influenza Drugs and Vaccines Sales Price by Country (2027-2032) & (US$/Kg) Table 215. Germany Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 216. France Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 217. U.K. Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 218. Italy Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 219. Russia Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 220. Spain Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 221. Netherlands Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 222. Switzerland Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 223. Sweden Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 224. Poland Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 225. China Influenza Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 226. China Influenza Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 227. China Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 228. China Influenza Drugs and Vaccines Sales by Type (2027-2032) & (Tons) Table 229. China Influenza Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Kg) Table 230. China Influenza Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Kg) Table 231. China Influenza Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 232. China Influenza Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 233. China Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 234. China Influenza Drugs and Vaccines Sales by Application (2027-2032) & (Tons) Table 235. China Influenza Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Kg) Table 236. China Influenza Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Kg) Table 237. Asia Influenza Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 238. Asia Influenza Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 239. Asia Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 240. Asia Influenza Drugs and Vaccines Sales by Type (2027-2032) & (Tons) Table 241. Asia Influenza Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Kg) Table 242. Asia Influenza Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Kg) Table 243. Asia Influenza Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 244. Asia Influenza Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 245. Asia Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 246. Asia Influenza Drugs and Vaccines Sales by Application (2027-2032) & (Tons) Table 247. Asia Influenza Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Kg) Table 248. Asia Influenza Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Kg) Table 249. Asia Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 250. Asia Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 251. Asia Influenza Drugs and Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 252. Asia Influenza Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 253. Asia Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 254. Asia Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 255. Asia Influenza Drugs and Vaccines Sales Price by Country (2021-2026) & (US$/Kg) Table 256. Asia Influenza Drugs and Vaccines Sales Price by Country (2027-2032) & (US$/Kg) Table 257. Japan Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 258. South Korea Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 259. India Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 260. Australia Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 261. Taiwan Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 262. Southeast Asia Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 263. SAMEA Influenza Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 264. SAMEA Influenza Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 265. SAMEA Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 266. SAMEA Influenza Drugs and Vaccines Sales by Type (2027-2032) & (Tons) Table 267. SAMEA Influenza Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Kg) Table 268. SAMEA Influenza Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Kg) Table 269. SAMEA Influenza Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 270. SAMEA Influenza Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 271. SAMEA Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 272. SAMEA Influenza Drugs and Vaccines Sales by Application (2027-2032) & (Tons) Table 273. SAMEA Influenza Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Kg) Table 274. SAMEA Influenza Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Kg) Table 275. SAMEA Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 276. SAMEA Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 277. SAMEA Influenza Drugs and Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 278. SAMEA Influenza Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 279. SAMEA Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 280. SAMEA Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 281. SAMEA Influenza Drugs and Vaccines Sales Price by Country (2021-2026) & (US$/Kg) Table 282. SAMEA Influenza Drugs and Vaccines Sales Price by Country (2027-2032) & (US$/Kg) Table 283. Brazil Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 284. Argentina Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 285. Chile Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 286. Colombia Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 287. Peru Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 288. Saudi Arabia Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 289. Israel Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 290. UAE Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 291. Turkey Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 292. Iran Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 293. Egypt Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 294. Key Raw Materials Table 295. Raw Materials Key Suppliers Table 296. Influenza Drugs and Vaccines Distributors List Table 297. Influenza Drugs and Vaccines Customers List Table 298. Research Programs/Design for This Report Table 299. Authors List of This Report Table 300. Secondary Sources Table 301. Primary Sources List of Figures Figure 1. Influenza Drugs and Vaccines Image Figure 2. Global Influenza Drugs and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza Drugs and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Influenza Drugs Image Figure 5. Influenza Vaccines Image Figure 6. Global Influenza Drugs and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Influenza Drugs and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacy Image Figure 9. Online Pharmacy Image Figure 10. Hospital Pharmacy Image Figure 11. Global Influenza Drugs and Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 13. Global Influenza Drugs and Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Influenza Drugs and Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2021-2032) Figure 16. Global Influenza Drugs and Vaccines Sales (2021-2032) & (Tons) Figure 17. Global Influenza Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 18. Global Influenza Drugs and Vaccines Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Influenza Drugs and Vaccines Sales YoY (2021-2032) & (Tons) Figure 20. Europe Influenza Drugs and Vaccines Sales YoY (2021-2032) & (Tons) Figure 21. China Influenza Drugs and Vaccines Sales YoY (2021-2032) & (Tons) Figure 22. Asia (Excluding China) Influenza Drugs and Vaccines Sales YoY (2021-2032) & (Tons) Figure 23. South America, Middle East and Africa Influenza Drugs and Vaccines Sales YoY (2021-2032) & (Tons) Figure 24. Global Influenza Drugs and Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Influenza Drugs and Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Influenza Drugs and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Influenza Drugs and Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2021-2032) Figure 30. Global Influenza Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 31. Global Influenza Drugs and Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Influenza Drugs and Vaccines Sales Market Share by Type (2021-2032) Figure 33. Global Influenza Drugs and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Influenza Drugs and Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2021-2032) Figure 36. Global Influenza Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Influenza Drugs and Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Influenza Drugs and Vaccines Sales Market Share by Application (2021-2032) Figure 39. North America Influenza Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 40. North America Influenza Drugs and Vaccines Sales Share by Type (2021-2032) Figure 41. North America Influenza Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 42. North America Influenza Drugs and Vaccines Sales Share by Application (2021-2032) Figure 43. North America Influenza Drugs and Vaccines Revenue Share by Country (2021-2032) Figure 44. North America Influenza Drugs and Vaccines Sales Share by Country (2021-2032) Figure 45. Europe Influenza Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 46. Europe Influenza Drugs and Vaccines Sales Share by Type (2021-2032) Figure 47. Europe Influenza Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 48. Europe Influenza Drugs and Vaccines Sales Share by Application (2021-2032) Figure 49. Europe Influenza Drugs and Vaccines Revenue Share by Country (2021-2032) Figure 50. Europe Influenza Drugs and Vaccines Sales Share by Country (2021-2032) Figure 51. China Influenza Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 52. China Influenza Drugs and Vaccines Sales Share by Type (2021-2032) Figure 53. China Influenza Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 54. China Influenza Drugs and Vaccines Sales Share by Application (2021-2032) Figure 55. Asia Influenza Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 56. Asia Influenza Drugs and Vaccines Sales Share by Type (2021-2032) Figure 57. Asia Influenza Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 58. Asia Influenza Drugs and Vaccines Sales Share by Application (2021-2032) Figure 59. Asia Influenza Drugs and Vaccines Revenue Share by Country (2021-2032) Figure 60. Asia Influenza Drugs and Vaccines Sales Share by Country (2021-2032) Figure 61. SAMEA Influenza Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 62. SAMEA Influenza Drugs and Vaccines Sales Share by Type (2021-2032) Figure 63. SAMEA Influenza Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 64. SAMEA Influenza Drugs and Vaccines Sales Share by Application (2021-2032) Figure 65. SAMEA Influenza Drugs and Vaccines Revenue Share by Country (2021-2032) Figure 66. SAMEA Influenza Drugs and Vaccines Sales Share by Country (2021-2032) Figure 67. Influenza Drugs and Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Influenza Drugs and Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Influenza Drugs
  • Influenza Vaccines
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • CSL
  • Alvogen
  • AstraZeneca
  • BioCryst Pharmaceuticals
  • Bristol Myers Squibb
  • Celgene
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Hulan Bio
  • Protein Sciences Corporation
  • Seqirus
  • Serum Institute of India
  • Viatris
  • Beike Bio
  • Bayer
  • Pfizer
  • Jiangsu GDK
  • Sinovac
  • Eli Lilly
  • Roche
  • Novartis
  • Sanofi
  • Changchun Institute of Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Influenza Drugs and Vaccines Market by Type
  3. 1.2.1 Global Influenza Drugs and Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Influenza Drugs
  5. 1.2.3 Influenza Vaccines
  6. 1.3 Influenza Drugs and Vaccines Market by Application
  7. 1.3.1 Global Influenza Drugs and Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacy
  9. 1.3.3 Online Pharmacy
  10. 1.3.4 Hospital Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Influenza Drugs and Vaccines Market Dynamics
  1. 2.1 Influenza Drugs and Vaccines Industry Trends
  2. 2.2 Influenza Drugs and Vaccines Industry Drivers
  3. 2.3 Influenza Drugs and Vaccines Industry Opportunities and Challenges
  4. 2.4 Influenza Drugs and Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Influenza Drugs and Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Influenza Drugs and Vaccines Revenue by Region
  3. 3.2.1 Global Influenza Drugs and Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Influenza Drugs and Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Influenza Drugs and Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Influenza Drugs and Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Influenza Drugs and Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Influenza Drugs and Vaccines Sales by Region
  9. 3.4.1 Global Influenza Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Influenza Drugs and Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Influenza Drugs and Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Influenza Drugs and Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Influenza Drugs and Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Influenza Drugs and Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Influenza Drugs and Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Influenza Drugs and Vaccines Sales by Manufacturers
  6. 4.2.1 Global Influenza Drugs and Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Influenza Drugs and Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Influenza Drugs and Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Influenza Drugs and Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Influenza Drugs and Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Influenza Drugs and Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Influenza Drugs and Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Influenza Drugs and Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Influenza Drugs and Vaccines Tier 1, Tier 2, and Tier 3
5 Influenza Drugs and Vaccines Market by Type
  1. 5.1 Global Influenza Drugs and Vaccines Revenue by Type
  2. 5.1.1 Global Influenza Drugs and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Influenza Drugs and Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Influenza Drugs and Vaccines Sales by Type
  6. 5.2.1 Global Influenza Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Influenza Drugs and Vaccines Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Influenza Drugs and Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Influenza Drugs and Vaccines Price by Type
6 Influenza Drugs and Vaccines Market by Application
  1. 6.1 Global Influenza Drugs and Vaccines Revenue by Application
  2. 6.1.1 Global Influenza Drugs and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Influenza Drugs and Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Influenza Drugs and Vaccines Sales by Application
  6. 6.2.1 Global Influenza Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Influenza Drugs and Vaccines Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Influenza Drugs and Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Influenza Drugs and Vaccines Price by Application
7 Company Profiles
  1. 7.1 CSL
  2. 7.1.1 CSL Company Information
  3. 7.1.2 CSL Business Overview
  4. 7.1.3 CSL Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSL Influenza Drugs and Vaccines Product Portfolio
  6. 7.1.5 CSL Recent Developments
  7. 7.2 Alvogen
  8. 7.2.1 Alvogen Company Information
  9. 7.2.2 Alvogen Business Overview
  10. 7.2.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Alvogen Influenza Drugs and Vaccines Product Portfolio
  12. 7.2.5 Alvogen Recent Developments
  13. 7.3 AstraZeneca
  14. 7.3.1 AstraZeneca Company Information
  15. 7.3.2 AstraZeneca Business Overview
  16. 7.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AstraZeneca Influenza Drugs and Vaccines Product Portfolio
  18. 7.3.5 AstraZeneca Recent Developments
  19. 7.4 BioCryst Pharmaceuticals
  20. 7.4.1 BioCryst Pharmaceuticals Company Information
  21. 7.4.2 BioCryst Pharmaceuticals Business Overview
  22. 7.4.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio
  24. 7.4.5 BioCryst Pharmaceuticals Recent Developments
  25. 7.5 Bristol Myers Squibb
  26. 7.5.1 Bristol Myers Squibb Company Information
  27. 7.5.2 Bristol Myers Squibb Business Overview
  28. 7.5.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio
  30. 7.5.5 Bristol Myers Squibb Recent Developments
  31. 7.6 Celgene
  32. 7.6.1 Celgene Company Information
  33. 7.6.2 Celgene Business Overview
  34. 7.6.3 Celgene Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Celgene Influenza Drugs and Vaccines Product Portfolio
  36. 7.6.5 Celgene Recent Developments
  37. 7.7 Emergent Biosolutions
  38. 7.7.1 Emergent Biosolutions Company Information
  39. 7.7.2 Emergent Biosolutions Business Overview
  40. 7.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
  42. 7.7.5 Emergent Biosolutions Recent Developments
  43. 7.8 GlaxoSmithKline
  44. 7.8.1 GlaxoSmithKline Company Information
  45. 7.8.2 GlaxoSmithKline Business Overview
  46. 7.8.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio
  48. 7.8.5 GlaxoSmithKline Recent Developments
  49. 7.9 Hulan Bio
  50. 7.9.1 Hulan Bio Company Information
  51. 7.9.2 Hulan Bio Business Overview
  52. 7.9.3 Hulan Bio Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hulan Bio Influenza Drugs and Vaccines Product Portfolio
  54. 7.9.5 Hulan Bio Recent Developments
  55. 7.10 Protein Sciences Corporation
  56. 7.10.1 Protein Sciences Corporation Company Information
  57. 7.10.2 Protein Sciences Corporation Business Overview
  58. 7.10.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio
  60. 7.10.5 Protein Sciences Corporation Recent Developments
  61. 7.11 Seqirus
  62. 7.11.1 Seqirus Company Information
  63. 7.11.2 Seqirus Business Overview
  64. 7.11.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Seqirus Influenza Drugs and Vaccines Product Portfolio
  66. 7.11.5 Seqirus Recent Developments
  67. 7.12 Serum Institute of India
  68. 7.12.1 Serum Institute of India Company Information
  69. 7.12.2 Serum Institute of India Business Overview
  70. 7.12.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Serum Institute of India Influenza Drugs and Vaccines Product Portfolio
  72. 7.12.5 Serum Institute of India Recent Developments
  73. 7.13 Viatris
  74. 7.13.1 Viatris Company Information
  75. 7.13.2 Viatris Business Overview
  76. 7.13.3 Viatris Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Viatris Influenza Drugs and Vaccines Product Portfolio
  78. 7.13.5 Viatris Recent Developments
  79. 7.14 Beike Bio
  80. 7.14.1 Beike Bio Company Information
  81. 7.14.2 Beike Bio Business Overview
  82. 7.14.3 Beike Bio Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Beike Bio Influenza Drugs and Vaccines Product Portfolio
  84. 7.14.5 Beike Bio Recent Developments
  85. 7.15 Bayer
  86. 7.15.1 Bayer Company Information
  87. 7.15.2 Bayer Business Overview
  88. 7.15.3 Bayer Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Bayer Influenza Drugs and Vaccines Product Portfolio
  90. 7.15.5 Bayer Recent Developments
  91. 7.16 Pfizer
  92. 7.16.1 Pfizer Company Information
  93. 7.16.2 Pfizer Business Overview
  94. 7.16.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Pfizer Influenza Drugs and Vaccines Product Portfolio
  96. 7.16.5 Pfizer Recent Developments
  97. 7.17 Jiangsu GDK
  98. 7.17.1 Jiangsu GDK Company Information
  99. 7.17.2 Jiangsu GDK Business Overview
  100. 7.17.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio
  102. 7.17.5 Jiangsu GDK Recent Developments
  103. 7.18 Sinovac
  104. 7.18.1 Sinovac Company Information
  105. 7.18.2 Sinovac Business Overview
  106. 7.18.3 Sinovac Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Sinovac Influenza Drugs and Vaccines Product Portfolio
  108. 7.18.5 Sinovac Recent Developments
  109. 7.19 Eli Lilly
  110. 7.19.1 Eli Lilly Company Information
  111. 7.19.2 Eli Lilly Business Overview
  112. 7.19.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Eli Lilly Influenza Drugs and Vaccines Product Portfolio
  114. 7.19.5 Eli Lilly Recent Developments
  115. 7.20 Roche
  116. 7.20.1 Roche Company Information
  117. 7.20.2 Roche Business Overview
  118. 7.20.3 Roche Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Roche Influenza Drugs and Vaccines Product Portfolio
  120. 7.20.5 Roche Recent Developments
  121. 7.21 Novartis
  122. 7.21.1 Novartis Company Information
  123. 7.21.2 Novartis Business Overview
  124. 7.21.3 Novartis Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Novartis Influenza Drugs and Vaccines Product Portfolio
  126. 7.21.5 Novartis Recent Developments
  127. 7.22 Sanofi
  128. 7.22.1 Sanofi Company Information
  129. 7.22.2 Sanofi Business Overview
  130. 7.22.3 Sanofi Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Sanofi Influenza Drugs and Vaccines Product Portfolio
  132. 7.22.5 Sanofi Recent Developments
  133. 7.23 Changchun Institute of Biological
  134. 7.23.1 Changchun Institute of Biological Company Information
  135. 7.23.2 Changchun Institute of Biological Business Overview
  136. 7.23.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio
  138. 7.23.5 Changchun Institute of Biological Recent Developments
8 North America
  1. 8.1 North America Influenza Drugs and Vaccines Market Size by Type
  2. 8.1.1 North America Influenza Drugs and Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Influenza Drugs and Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Influenza Drugs and Vaccines Price by Type (2021-2032)
  5. 8.2 North America Influenza Drugs and Vaccines Market Size by Application
  6. 8.2.1 North America Influenza Drugs and Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Influenza Drugs and Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Influenza Drugs and Vaccines Price by Application (2021-2032)
  9. 8.3 North America Influenza Drugs and Vaccines Market Size by Country
  10. 8.3.1 North America Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Influenza Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Influenza Drugs and Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Influenza Drugs and Vaccines Market Size by Type
  2. 9.1.1 Europe Influenza Drugs and Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Influenza Drugs and Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Influenza Drugs and Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Influenza Drugs and Vaccines Market Size by Application
  6. 9.2.1 Europe Influenza Drugs and Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Influenza Drugs and Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Influenza Drugs and Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Influenza Drugs and Vaccines Market Size by Country
  10. 9.3.1 Europe Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Influenza Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Influenza Drugs and Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Influenza Drugs and Vaccines Market Size by Type
  2. 10.1.1 China Influenza Drugs and Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Influenza Drugs and Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Influenza Drugs and Vaccines Price by Type (2021-2032)
  5. 10.2 China Influenza Drugs and Vaccines Market Size by Application
  6. 10.2.1 China Influenza Drugs and Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Influenza Drugs and Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Influenza Drugs and Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Influenza Drugs and Vaccines Market Size by Type
  2. 11.1.1 Asia Influenza Drugs and Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Influenza Drugs and Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Influenza Drugs and Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Influenza Drugs and Vaccines Market Size by Application
  6. 11.2.1 Asia Influenza Drugs and Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Influenza Drugs and Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Influenza Drugs and Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Influenza Drugs and Vaccines Market Size by Country
  10. 11.3.1 Asia Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Influenza Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Influenza Drugs and Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Influenza Drugs and Vaccines Market Size by Type
  2. 12.1.1 SAMEA Influenza Drugs and Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Influenza Drugs and Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Influenza Drugs and Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Influenza Drugs and Vaccines Market Size by Application
  6. 12.2.1 SAMEA Influenza Drugs and Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Influenza Drugs and Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Influenza Drugs and Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Influenza Drugs and Vaccines Market Size by Country
  10. 12.3.1 SAMEA Influenza Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Influenza Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Influenza Drugs and Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Influenza Drugs and Vaccines Value Chain Analysis
  2. 13.1.1 Influenza Drugs and Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Influenza Drugs and Vaccines Production Mode & Process
  6. 13.2 Influenza Drugs and Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Influenza Drugs and Vaccines Distributors
  9. 13.2.3 Influenza Drugs and Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst